AMSF — AMERISAFE, Inc.
NASDAQ
Q2 2026 Earnings Call Summary
July 22, 2026
AMERISAFE Q2 2026 Earnings Call Summary
1. Key Financial Results and Metrics:
- Net Income: $14.6 million ($0.78 per diluted share), up from $14 million ($0.73 per diluted share) in Q2 2025.
- Operating Net Income: $8.3 million ($0.44 per diluted share), down from $10 million ($0.53 per diluted share) in Q2 2025.
- Gross Written Premiums: Increased 7.9% to $86 million from $79.7 million.
- Net Premiums Earned: Increased 11.4% to $77.3 million from $69.4 million.
- Expense Ratio: 31.8%, slightly up from 31.3% due to a one-time bad debt write-off of approximately $700,000.
- Return on Average Equity: 23.5%.
- Investment Income: $6.5 million, down 2.4% from the previous year.
- Statutory Surplus: $200.8 million, down from $217.8 million at year-end 2025.
- Book Value per Share: Increased to $13.49, a 0.7% increase year-to-date.
2. Strategic Updates and Business Highlights:
- Continued premium growth for the ninth consecutive quarter, driven by strong renewal retention (over 93%) and favorable audit premium activity.
- Payroll growth among insureds remains healthy, indicating robust economic activity.
- AMERISAFE's specialized underwriting in high-hazard industries and disciplined pricing strategies are key differentiators in a competitive market.
- The company repurchased approximately 181,000 shares at an average price of $30.58, returning $5.6 million to shareholders.
3. Forward Guidance and Outlook:
- AMERISAFE aims to balance profitable growth, underwriting discipline, and long-term shareholder value creation despite a gradually softening market.
- The company remains optimistic about its ability to maintain mid-single-digit growth trajectories and strong customer retention.
4. Bad News, Challenges, or Points of Concern:
- The workers' compensation market is experiencing gradual softening, with rate reductions, increasing medical costs, and heightened competition impacting industry-wide results.
- Claim frequency has increased, returning closer to 2023 levels, although severity has decreased.
- The company noted challenges with medical inflation, which is expected to persist, impacting future costs.
- The competitive landscape is intensifying, with larger players becoming more aggressive, potentially affecting AMERISAFE's growth.
5. Notable Q&A Insights:
- Management acknowledged increased competition, particularly from package carriers, but did not attribute it solely to larger players.
- Strong audit activity was highlighted, with wage growth among insureds contributing positively to future audit premiums.
- The company is focused on retaining profitable accounts and maintaining disciplined pricing strategies amidst competitive pressures.
- Concerns were raised about medical inflation and its impact on claims, with management emphasizing the importance of adhering to fee schedules to control costs.
- The discussion included insights on California's recent rate increase and its potential implications for broader market trends, indicating a recognition of rising costs despite ongoing rate reductions in many regions.
Overall, AMERISAFE reported solid financial performance in Q2 2026, but faces ongoing challenges in a competitive and softening market environment.
